• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911416350
Device Problem Occlusion Within Device (1423)
Patient Problems Chest Pain (1776); Dyspnea (1816); Nausea (1970); Reocclusion (1985); Diaphoresis (2452)
Event Date 10/11/2016
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
(b)(4) clinical study.It was reported that chest pain and in-stent restenosis (isr) occurred.In (b)(6) 2013, the patient presented due to angina.Subsequently, coronary angiography and index procedure were performed.The target lesion #1 was a de novo lesion located in the distal left circumflex (lcx) with 90 % stenosis and was 10mm long with a reference vessel diameter of 2.75 m.The lesion #1 was treated with direct placement of a 2.75x12 mm promus element¿ plus drug-eluting stent, with 0% residual stenosis.The target lesion #2 was a de novo lesion located in the proximal lcx with 95% stenosis and was 10mm long with a reference vessel diameter of 3.5mm.The lesion #2 was treated with direct stent placement using a 3.50x16mm promus element¿ plus drug-eluting stent with 0% residual stenosis.Additionally, 90% in-stent restenosis (isr) of unknown stent located in the ramus was treated with angioplasty with 10% residual stenosis.Post deployment of the 3.50x16mm promus element¿ plus study stent in the proximal circumflex, some material of the plaque was shifted in to the ramus which was further treated by balloon angioplasty with a non-compliant balloon with 0% residual stenosis and timi-3 flow.One day post procedure, the patient was discharged on clopidogrel.In (b)(6) 2016, the patient was presented with complaints of exertional chest pain, pressure associated with shortness of breath, diaphoresis and nausea.Subsequently, the patient was hospitalized on the same day and patient was further referred for cardiac catheterization.Coronary angiography revealed a 90% isr of the 3.50x16mm promus element¿ plus study stent located in proximal lcx and was treated with angioplasty with 10% residual stenosis.Additionally, the 90% isr of unknown stent located in ramus was treated with angioplasty with 10% residual stenosis.On the following day, the event was considered as resolved and the patient was discharged on the same day on plavix.
 
Manufacturer Narrative
Event date: updated and corrected from 10/24/2016 to 10/11/2016.Describe event or problem, relevant tests/lab data, other relevant history updated.(b)(4).
 
Event Description
It was further reported that in (b)(6) 2016, the patient visited the study hospital and patient was planned for cardiac catheterization.Thirteen days later, the patient returned to hospital for the planned cardiac catheterization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6298916
MDR Text Key66430703
Report Number2134265-2017-00724
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/20/2013
Device Model NumberH7493911416350
Device Catalogue Number39114-1635
Device Lot Number15346502
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/17/2017
Initial Date FDA Received02/02/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/21/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/10/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age61 YR
-
-